ACST - 1.25 Bid/Ask inching up in pre-market. Acasti Pharma Reports Positive Data from Study of CaPre to Treat Hypertriglyceridemia http://stockcharts.com/c-sc/sc?s=ACST&p=D&b=5&g=0&i=t39818855606&r=1473856340541 http://stockcharts.com/c-sc/sc?s=ACST&p=W&b=5&g=0&i=t08545571535&r=1473856430753